Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Hereditary Breast and Ovarian Cancer Panel QDx Pathology Services, Inc. United States | 3 | 23 |
|
QDx Pathology Services, Inc. United States | 15 | 44 |
|
Personalis, Inc. United States | 1 | 413 |
|
Genetic Services Laboratory University of Chicago United States | 7 | 15 |
|
Tempus AI - RTP United States | 2 | 647 |
|
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States | 97 | 77 |
|
SMARCA4 Gene Mental retardation, autosomal dominant type 16 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 19 |
|
Hereditary Expanded Cancer Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 86 |
|
Tempus AI - CHI United States | 2 | 647 |
|
Rhabdoid Tumor Predisposition Syndrome NGS Panel UAB Medical Genomics Laboratory UAB Medicine United States | 5 | 2 |
|
Foundation Medicine, Inc. United States | 2 | 405 |
|
Rhabdoid tumor predisposition syndrome testing (SMARCA4) Genetic Services Laboratory University of Chicago United States | 1 | 1 |
|
Small cell carcinoma of the ovary, hypercalcemic type Molecular Genetics Laboratory North York General Hospital Canada | 1 | 1 |
|
Rhabdoid predisposition syndrome Molecular Genetics Laboratory North York General Hospital Canada | 1 | 2 |
|
Comprehensive cancer panel (76 genes) Molecular Genetics Laboratory North York General Hospital Canada | 1 | 74 |
|
NEXT GEN SEQUENCING COMPREHENSIVE SOLID TUMOR PANEL Alverno Laboratories United States | 1 | 27 |
|
OncoAlly™ Comprehensive Hereditary Cancer Analysis Variantyx, Inc. United States | 1 | 88 |
|
OnkoSight Advanced Bladder Cancer Panel BioReference Health United States | 1 | 39 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics, part of Exact Sciences United States | 94 | 55 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.